ATE505538T1 - Dna-vektoren - Google Patents
Dna-vektorenInfo
- Publication number
- ATE505538T1 ATE505538T1 AT04754961T AT04754961T ATE505538T1 AT E505538 T1 ATE505538 T1 AT E505538T1 AT 04754961 T AT04754961 T AT 04754961T AT 04754961 T AT04754961 T AT 04754961T AT E505538 T1 ATE505538 T1 AT E505538T1
- Authority
- AT
- Austria
- Prior art keywords
- dna vectors
- cancer
- treatment
- methods
- present
- Prior art date
Links
- 239000013598 vector Substances 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47723203P | 2003-06-09 | 2003-06-09 | |
| PCT/US2004/018529 WO2005002509A2 (en) | 2003-06-09 | 2004-06-09 | Dna vectors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE505538T1 true ATE505538T1 (de) | 2011-04-15 |
Family
ID=33563762
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04754961T ATE505538T1 (de) | 2003-06-09 | 2004-06-09 | Dna-vektoren |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20100150968A1 (de) |
| EP (1) | EP1639109B1 (de) |
| JP (1) | JP4771954B2 (de) |
| AT (1) | ATE505538T1 (de) |
| CA (1) | CA2528094A1 (de) |
| DE (1) | DE602004032235D1 (de) |
| ES (1) | ES2363972T3 (de) |
| WO (1) | WO2005002509A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4461179B2 (ja) | 2005-02-25 | 2010-05-12 | オンコセラピー・サイエンス株式会社 | Ｔｔｋ、ｕｒｌｃ１０、またはｋｏｃ１ポリペプチドを発現する肺癌に対するペプチドワクチン |
| MY149604A (en) * | 2005-04-18 | 2013-09-13 | Schering Plough Ltd | C.perfringens alpha toxoid vaccine |
| JP2010526485A (ja) | 2007-04-30 | 2010-07-29 | インターデイジタル テクノロジー コーポレーション | マルチメディアブロードキャスト／マルチキャストサービスに関するセル再選択およびハンドオーバ |
| US20120129770A1 (en) * | 2009-06-22 | 2012-05-24 | Rajyashri Karur Ramakrishna | Novel polynucleotide molecules for enhanced gene expression |
| JP6148666B2 (ja) * | 2011-04-15 | 2017-06-14 | セシリア ノークレール | サイトメガロウイルス（ｃｍｖ）の遺伝子変異体 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ244306A (en) * | 1991-09-30 | 1995-07-26 | Boehringer Ingelheim Int | Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation |
| US6518256B1 (en) * | 1998-03-18 | 2003-02-11 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
| EP1078092B1 (de) * | 1998-05-13 | 2011-08-03 | Epimmune Inc. | Expressionsvektoren zur stimulierung einer immunantwort und verfahren zu deren verwendung |
| DE60118798T2 (de) * | 2000-10-13 | 2007-04-12 | Chiron Corp., Emeryville | Fragmente des introns a des cytomegalovirus |
-
2004
- 2004-06-09 ES ES04754961T patent/ES2363972T3/es not_active Expired - Lifetime
- 2004-06-09 US US10/559,596 patent/US20100150968A1/en not_active Abandoned
- 2004-06-09 AT AT04754961T patent/ATE505538T1/de not_active IP Right Cessation
- 2004-06-09 JP JP2006533703A patent/JP4771954B2/ja not_active Expired - Fee Related
- 2004-06-09 EP EP04754961A patent/EP1639109B1/de not_active Expired - Lifetime
- 2004-06-09 WO PCT/US2004/018529 patent/WO2005002509A2/en active Application Filing
- 2004-06-09 DE DE602004032235T patent/DE602004032235D1/de not_active Expired - Lifetime
- 2004-06-09 CA CA002528094A patent/CA2528094A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005002509A3 (en) | 2005-06-02 |
| EP1639109A4 (de) | 2007-07-04 |
| US20100150968A1 (en) | 2010-06-17 |
| WO2005002509A2 (en) | 2005-01-13 |
| CA2528094A1 (en) | 2005-01-13 |
| EP1639109A2 (de) | 2006-03-29 |
| JP4771954B2 (ja) | 2011-09-14 |
| ES2363972T3 (es) | 2011-08-22 |
| EP1639109B1 (de) | 2011-04-13 |
| DE602004032235D1 (de) | 2011-05-26 |
| JP2007506443A (ja) | 2007-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1119263T1 (el) | Συνθεσεις και μεθοδοι για την αυξηση της ασβεστοποιησεως των οστων | |
| IL226717A (en) | Isolated nucleic acids encoded by anti-beta human antibodies 7 | |
| CY1109741T1 (el) | Sns-595 και μεθοδοι χρησης αυτου | |
| YU9404A (sh) | Multimerna, usmerena kontrastna sredstva na bazi peptida | |
| IL190796A (en) | Composition containing nucleic acid encoded by anti-osteoclastogenic protein | |
| CY1112055T1 (el) | Συνθεσεις και μεθοδοι για την διαγνωση και θεραπευτικη αγωγη ογκου πνευμονα | |
| ATE267830T1 (de) | Als cox-hemmer verwendbare sulfonylphenylpyrazol- verbindungen | |
| TW200732349A (en) | Anti-OX40L antibodies and methods using same | |
| MY136095A (en) | Use of human anti-ctla-4 antibodies for treatment of cancer | |
| DE60314500D1 (de) | Diaminopyrimidine und deren verwendung als angiogenesehemmer | |
| TW200611910A (en) | Interferon-alpha polypeptides and conjugates | |
| DK1572087T3 (da) | Antistoffer med cancerantigen TMEFF2 og anvendelser deraf | |
| DE602004027637D1 (de) | Verwendung von cupredoxin-proteine für krebstherapie | |
| ATE466080T1 (de) | Formulierungen und verfahren zum denaturieren von proteinen | |
| WO2003104425A3 (en) | NEW STABLE ANTI-CD22 ANTIBODIES | |
| ATE543833T1 (de) | Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen | |
| DE60230456D1 (de) | Faktor-viii-polypeptide auf hohem expressionsnivea und verwendungsverfahren | |
| SE0301650D0 (sv) | Novel compounds | |
| DK1572959T3 (da) | Hybridpolymerase-fremgangsmåder og -sammensætninger | |
| MX2007011411A (es) | Interaccion rage/diaphanous y composiciones relacionadas y metodos. | |
| ATE505538T1 (de) | Dna-vektoren | |
| DE60326773D1 (de) | Peptid-deformylase-hemmer | |
| NO20053903D0 (no) | Nukleotidlipidesterderivater. | |
| ATE420162T1 (de) | Verfahren und zusammensetzungen zum targeting sekretorischer lysosomen | |
| DK1377667T3 (da) | Fusionsproteiner til specifik behandling af cancer og autoimmunsygdomme |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |